Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes

Background: The impact of COVID-19 on respiratory outcomes in people with cystic fibrosis (pwCF) has not been clearly characterized. We evaluated changes in respiratory function indicators derived from spirometry and pulmonary exacerbation rates 6 months after SARS-CoV-2 infection. Methods: This mul...

Full description

Bibliographic Details
Main Authors: Paola Medino, Gianfranco Alicandro, Chiara Rosazza, Fabiana Ciciriello, Andrea Gramegna, Arianna Biffi, Valeria Daccò, Vincenzina Lucidi, Marco Cipolli, Mariaserena Boraso, Erica Nazzari, Carla Colombo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
COVID-19
cystic fibrosis
respiratory outcomes
ppFEV1
pulmonary exacerbation
Online Access:https://www.mdpi.com/2227-9059/10/11/2771

Internet

https://www.mdpi.com/2227-9059/10/11/2771

Similar Items